Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 May 15;316(Pt 1):311–316. doi: 10.1042/bj3160311

KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.

M Ichimura 1, R Eiki 1, K Osawa 1, S Nakanishi 1, H Kase 1
PMCID: PMC1217340  PMID: 8645223

Abstract

The effects of KS-505a, a novel microbial metabolite, on the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase (CaM-PDE) were investigated. (1) KS-505a potently inhibited the purified 61 kDa isoenzyme of CaM-PDE from bovine brain and required much higher doses to inhibit the purified 59 kDa isoenzyme of CaM-PDE from bovine heart. The inhibition of both isoenzymes was observed only in the presence of calcium-activated calmodulin (Ca2+/CaM). The IC50 values for the 61 and 59 kDa isoenzymes were 0.17 and 13 microM respectively with 20 microM cAMP as a substrate. (2) Kinetic analysis indicated that the inhibitory mode of KS-505a for the 61 kDa isoenzyme was competitive with respect to Ca2+/CaM; the K1 for KS-505a was 0.089 microM. The inhibition was not competitive with respect to the substrates cAMP or cGMP. (3) KS-505a did not interfere with the interaction between Ca2+/CaM and n-phenyll-naphthylamine, a hydrophobic fluorescent probe, nor was it adsorbed to CaM-conjugated gels in the presence of Ca2+, thereby indicating that KS-505a does not bind to Ca2+/CaM. (4) Trypsin-activated 61 kDa isoenzyme, which lacked the Ca2+/CaM-binding domain, was not inhibited by KS-505a at less than micromolar concentrations. Taken together, these results suggest that KS-505a apparently bound to a site in the Ca2+/CaM-binding domain of the 61 kDa isoenzyme and selectively inhibited Ca2+/CaM-activated 61 kDa isoenzyme activity. (5) In rat hippocampal slices, KS-505a at 10 micronM increased the intracellular cAMP concentration to approximately three times the basal level, whereas in rat striatal slices it had no effect on the cAMP concentration at concentrations of 1.0-10 microM, suggesting that each CaM-PDE isoenzyme functions differentially in these regions. These results demonstrate that KS-505a is a highly potent selective inhibitor both in vitro and in vivo and distinguishes between subfamily members within the CaM-PDE family.

Full Text

The Full Text of this article is available as a PDF (368.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adunyah E. S., Niggli V., Carafoli E. The anticalmodulin drugs trifluoperazine and R24571 remove the activation of the purified erythrocyte Ca2+-ATPase by acidic phospholipids and by controlled proteolysis. FEBS Lett. 1982 Jun 21;143(1):65–68. doi: 10.1016/0014-5793(82)80274-3. [DOI] [PubMed] [Google Scholar]
  2. Beavo J. A., Conti M., Heaslip R. J. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol. 1994 Sep;46(3):399–405. [PubMed] [Google Scholar]
  3. Beavo J. A., Reifsnyder D. H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 1990 Apr;11(4):150–155. doi: 10.1016/0165-6147(90)90066-H. [DOI] [PubMed] [Google Scholar]
  4. Bentley J. K., Kadlecek A., Sherbert C. H., Seger D., Sonnenburg W. K., Charbonneau H., Novack J. P., Beavo J. A. Molecular cloning of cDNA encoding a "63"-kDa calmodulin-stimulated phosphodiesterase from bovine brain. J Biol Chem. 1992 Sep 15;267(26):18676–18682. [PubMed] [Google Scholar]
  5. Charbonneau H., Kumar S., Novack J. P., Blumenthal D. K., Griffin P. R., Shabanowitz J., Hunt D. F., Beavo J. A., Walsh K. A. Evidence for domain organization within the 61-kDa calmodulin-dependent cyclic nucleotide phosphodiesterase from bovine brain. Biochemistry. 1991 Aug 13;30(32):7931–7940. doi: 10.1021/bi00246a009. [DOI] [PubMed] [Google Scholar]
  6. DIXON M. The determination of enzyme inhibitor constants. Biochem J. 1953 Aug;55(1):170–171. doi: 10.1042/bj0550170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frey U., Huang Y. Y., Kandel E. R. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science. 1993 Jun 11;260(5114):1661–1664. doi: 10.1126/science.8389057. [DOI] [PubMed] [Google Scholar]
  8. Garthwaite J., Garthwaite G. Cellular origins of cyclic GMP responses to excitatory amino acid receptor agonists in rat cerebellum in vitro. J Neurochem. 1987 Jan;48(1):29–39. doi: 10.1111/j.1471-4159.1987.tb13123.x. [DOI] [PubMed] [Google Scholar]
  9. Gopalakrishna R., Anderson W. B. Ca2+-induced hydrophobic site on calmodulin: application for purification of calmodulin by phenyl-Sepharose affinity chromatography. Biochem Biophys Res Commun. 1982 Jan 29;104(2):830–836. doi: 10.1016/0006-291x(82)90712-4. [DOI] [PubMed] [Google Scholar]
  10. Hansen R. S., Charbonneau H., Beavo J. A. Purification of calmodulin-stimulated cyclic nucleotide phosphodiesterase by monoclonal antibody affinity chromatography. Methods Enzymol. 1988;159:543–557. doi: 10.1016/0076-6879(88)59053-5. [DOI] [PubMed] [Google Scholar]
  11. Itoh H., Hidaka H. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase. J Biochem. 1984 Dec;96(6):1721–1726. doi: 10.1093/oxfordjournals.jbchem.a135004. [DOI] [PubMed] [Google Scholar]
  12. Kakiuchi S., Sobue K., Yamazaki R., Kambayashi J., Sakon M., Kosaki G. Lack of tissue specificity of calmodulin: a rapid and high-yield purification method. FEBS Lett. 1981 Apr 20;126(2):203–207. doi: 10.1016/0014-5793(81)80242-6. [DOI] [PubMed] [Google Scholar]
  13. Kincaid R. L., Manganiello V. C. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates. Methods Enzymol. 1988;159:457–470. doi: 10.1016/0076-6879(88)59045-6. [DOI] [PubMed] [Google Scholar]
  14. Kincaid R. L., Manganiello V. C., Odya C. E., Osborne J. C., Jr, Stith-Coleman I. E., Danello M. A., Vaughan M. Purification and properties of calmodulin-stimulated phosphodiesterase from mammalian brain. J Biol Chem. 1984 Apr 25;259(8):5158–5166. [PubMed] [Google Scholar]
  15. Kincaid R. L., Stith-Coleman I. E., Vaughan M. Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase. J Biol Chem. 1985 Jul 25;260(15):9009–9015. [PubMed] [Google Scholar]
  16. LaPorte D. C., Toscano W. A., Jr, Storm D. R. Cross-linking of iodine-125-labeled, calcium-dependent regulatory protein to the Ca2+-sensitive phosphodiesterase purified from bovine heart. Biochemistry. 1979 Jun 26;18(13):2820–2825. doi: 10.1021/bi00580a021. [DOI] [PubMed] [Google Scholar]
  17. Matsuda Y., Nakanishi S., Nagasawa K., Kase H. Inhibition by new anthraquinone compounds, K-259-2 and KS-619-1, of calmodulin-dependent cyclic nucleotide phosphodiesterase. Biochem Pharmacol. 1990 Mar 1;39(5):841–849. doi: 10.1016/0006-2952(90)90198-t. [DOI] [PubMed] [Google Scholar]
  18. Nakanishi S., Osawa K., Saito Y., Kawamoto I., Kuroda K., Kase H. KS-505a, a novel inhibitor of bovine brain Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Streptomyces argenteolus. J Antibiot (Tokyo) 1992 Mar;45(3):341–347. doi: 10.7164/antibiotics.45.341. [DOI] [PubMed] [Google Scholar]
  19. Nakanishi S., Yamada K., Kase H., Nakamura S., Nonomura Y. K-252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase. J Biol Chem. 1988 May 5;263(13):6215–6219. [PubMed] [Google Scholar]
  20. Nicholson C. D., Challiss R. A., Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci. 1991 Jan;12(1):19–27. doi: 10.1016/0165-6147(91)90484-a. [DOI] [PubMed] [Google Scholar]
  21. Novack J. P., Charbonneau H., Bentley J. K., Walsh K. A., Beavo J. A. Sequence comparison of the 63-, 61-, and 59-kDa calmodulin-dependent cyclic nucleotide phosphodiesterases. Biochemistry. 1991 Aug 13;30(32):7940–7947. doi: 10.1021/bi00246a010. [DOI] [PubMed] [Google Scholar]
  22. Polli J. W., Kincaid R. L. Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci. 1994 Mar;14(3 Pt 1):1251–1261. doi: 10.1523/JNEUROSCI.14-03-01251.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Polli J. W., Kincaid R. L. Molecular cloning of DNA encoding a calmodulin-dependent phosphodiesterase enriched in striatum. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):11079–11083. doi: 10.1073/pnas.89.22.11079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Repaske D. R., Swinnen J. V., Jin S. L., Van Wyk J. J., Conti M. A polymerase chain reaction strategy to identify and clone cyclic nucleotide phosphodiesterase cDNAs. Molecular cloning of the cDNA encoding the 63-kDa calmodulin-dependent phosphodiesterase. J Biol Chem. 1992 Sep 15;267(26):18683–18688. [PubMed] [Google Scholar]
  25. Sharma R. K., Kalra J. Ginsenosides are potent and selective inhibitors of some calmodulin-dependent phosphodiesterase isozymes. Biochemistry. 1993 May 18;32(19):4975–4978. doi: 10.1021/bi00070a001. [DOI] [PubMed] [Google Scholar]
  26. Sharma R. K., Wang T. H., Wirch E., Wang J. H. Purification and properties of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase. J Biol Chem. 1980 Jun 25;255(12):5916–5923. [PubMed] [Google Scholar]
  27. Silver P. J., Hamel L. T., Perrone M. H., Bentley R. G., Bushover C. R., Evans D. B. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. Eur J Pharmacol. 1988 May 20;150(1-2):85–94. doi: 10.1016/0014-2999(88)90753-4. [DOI] [PubMed] [Google Scholar]
  28. Sonnenburg W. K., Seger D., Beavo J. A. Molecular cloning of a cDNA encoding the "61-kDa" calmodulin-stimulated cyclic nucleotide phosphodiesterase. Tissue-specific expression of structurally related isoforms. J Biol Chem. 1993 Jan 5;268(1):645–652. [PubMed] [Google Scholar]
  29. Torphy T. J., Cieslinski L. B. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle. Mol Pharmacol. 1990 Feb;37(2):206–214. [PubMed] [Google Scholar]
  30. Yan C., Bentley J. K., Sonnenburg W. K., Beavo J. A. Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain. J Neurosci. 1994 Mar;14(3 Pt 1):973–984. doi: 10.1523/JNEUROSCI.14-03-00973.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yazawa M., Sakuma M., Yagi K. Calmodulins from muscles of marine invertebrates, scallop and sea anemone. J Biochem. 1980 May;87(5):1313–1320. doi: 10.1093/oxfordjournals.jbchem.a132869. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES